MedTrace Logo

A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

NCT05282914 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-07-03

No results posted yet for this study

Summary

A Study to compare pharmacokinetics, pharmacodynamics and safety of UI058 and UIC202004 in healthy subjects

Conditions

  • GERD

Interventions

DRUG

administration of UI058

UI058 1Tab/day for 7days

DRUG

administration of UIC202004

UIC202004 1Tab/day for 7days

Sponsors & Collaborators

  • Korea United Pharm. Inc.

    lead INDUSTRY

Principal Investigators

  • Min Kyu Park, Dr · Chungbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-03
Primary Completion
2021-04-14
Completion
2021-09-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05282914 on ClinicalTrials.gov